Literature DB >> 28304043

The mechanism of aquaporin inhibition by gold compounds elucidated by biophysical and computational methods.

Andreia de Almeida1, Andreia F Mósca2, Darren Wragg1, Margot Wenzel1, Paul Kavanagh3, Giampaolo Barone4, Stefano Leoni1, Graça Soveral2, Angela Casini1.   

Abstract

The inhibition of water and glycerol permeation via human aquaglyceroporin-3 (AQP3) by gold(iii) complexes has been studied by stopped-flow spectroscopy and, for the first time, its mechanism has been described using molecular dynamics (MD), combined with density functional theory (DFT) and electrochemical studies. The obtained MD results showed that the most effective gold-based inhibitor, anchored to Cys40 in AQP3, is able to induce shrinkage of pores preventing glycerol and water permeation. Moreover, the good correlation between the affinity of the Au(iii) complex to Cys binding and AQP3 inhibition effects was highlighted, while no influence of the different oxidative character of the complexes could be observed.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28304043     DOI: 10.1039/c7cc00318h

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  14 in total

1.  Inhibition Mechanism of Urease by Au(III) Compounds Unveiled by X-ray Diffraction Analysis.

Authors:  Luca Mazzei; Margot N Wenzel; Michele Cianci; Marta Palombo; Angela Casini; Stefano Ciurli
Journal:  ACS Med Chem Lett       Date:  2019-01-04       Impact factor: 4.345

Review 2.  Aquaporin ion conductance properties defined by membrane environment, protein structure, and cell physiology.

Authors:  Sam W Henderson; Saeed Nourmohammadi; Sunita A Ramesh; Andrea J Yool
Journal:  Biophys Rev       Date:  2022-01-11

3.  Rollover Cyclometalation vs Nitrogen Coordination in Tetrapyridyl Anticancer Gold(III) Complexes: Effect on Protein Interaction and Toxicity.

Authors:  Xue-Quan Zhou; Imma Carbo-Bague; Maxime A Siegler; Jonathan Hilgendorf; Uttara Basu; Ingo Ott; Rongfang Liu; Liyan Zhang; Vadde Ramu; Adriaan P IJzerman; Sylvestre Bonnet
Journal:  JACS Au       Date:  2021-03-16

4.  Computational Modeling on Aquaporin-3 as Skin Cancer Target: A Virtual Screening Study.

Authors:  Dharmendra Kumar Yadav; Surendra Kumar; Eun-Ha Choi; Sandeep Chaudhary; Mi-Hyun Kim
Journal:  Front Chem       Date:  2020-04-15       Impact factor: 5.221

5.  The Aquaporin-3-Inhibiting Potential of Polyoxotungstates.

Authors:  Catarina Pimpão; Inês V da Silva; Andreia F Mósca; Jacinta O Pinho; Maria Manuela Gaspar; Nadiia I Gumerova; Annette Rompel; Manuel Aureliano; Graça Soveral
Journal:  Int J Mol Sci       Date:  2020-04-02       Impact factor: 5.923

6.  Cyclometalated AuIII Complexes for Cysteine Arylation in Zinc Finger Protein Domains: towards Controlled Reductive Elimination.

Authors:  Margot N Wenzel; Riccardo Bonsignore; Sophie R Thomas; Didier Bourissou; Giampaolo Barone; Angela Casini
Journal:  Chemistry       Date:  2019-05-09       Impact factor: 5.236

Review 7.  Emergent Nanotechnological Strategies for Systemic Chemotherapy against Melanoma.

Authors:  Jacinta Oliveira Pinho; Mariana Matias; Maria Manuela Gaspar
Journal:  Nanomaterials (Basel)       Date:  2019-10-13       Impact factor: 5.076

8.  A Novel Hybrid Nanosystem Integrating Cytotoxic and Magnetic Properties as a Tool to Potentiate Melanoma Therapy.

Authors:  Nuno Cruz; Jacinta Oliveira Pinho; Graça Soveral; Lia Ascensão; Nuno Matela; Catarina Reis; Maria Manuela Gaspar
Journal:  Nanomaterials (Basel)       Date:  2020-04-06       Impact factor: 5.076

Review 9.  Aquaglyceroporins: Drug Targets for Metabolic Diseases?

Authors:  Giuseppe Calamita; Jason Perret; Christine Delporte
Journal:  Front Physiol       Date:  2018-07-10       Impact factor: 4.566

10.  Comparing the Antileishmanial Activity of Gold(I) and Gold(III) Compounds in L. amazonensis and L. braziliensis in Vitro.

Authors:  Karen Minori; Letícia B Rosa; Riccardo Bonsignore; Angela Casini; Danilo C Miguel
Journal:  ChemMedChem       Date:  2020-09-28       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.